Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.9% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
0
users have commented on this narrative
36
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.0% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
CrowdStrike Holdings
AN
AnalystLowTarget
Consensus Narrative from 47 Analysts
Intensifying Regulations And Rivalry Will Erode Future Prospects
Key Takeaways Escalating regulatory, competitive, and geopolitical pressures threaten growth, market share, and profitability through increased costs and reduced international opportunities. Rising adoption of AI threats and open-source alternatives forces heavier investment and creates sustained pricing pressure on premium cybersecurity offerings.
View narrative
US$364.31
FV
16.6% overvalued
intrinsic discount
21.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
5 days ago
author updated this narrative
Cadence Design Systems
AN
AnalystLowTarget
Consensus Narrative from 23 Analysts
US-China Frictions And Open-Source Trends Will Dampen EDA Prospects
Key Takeaways Growing adoption of open-source alternatives, stronger competition, and customer concentration risk threaten pricing power, revenue growth, and earnings stability. Geopolitical tensions and maturing semiconductor trends may restrict market access and limit long-term expansion opportunities.
View narrative
US$274.28
FV
27.2% overvalued
intrinsic discount
9.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
Analog Devices
AN
AnalystLowTarget
Consensus Narrative from 32 Analysts
Rising Costs And Fragmented Supply Chains Will Erode Margins
Key Takeaways Rising supply chain costs, reliance on Asian foundries, and escalating competition threaten margins, pricing power, and long-term revenue growth. High R&D spending, cyclical customer exposure, and sector volatility could drive earnings instability and constrain future financial recovery.
View narrative
US$186.59
FV
26.6% overvalued
intrinsic discount
10.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Micron Technology
AN
AnalystLowTarget
Consensus Narrative from 34 Analysts
Geopolitical Tensions And Rising Costs Will Hinder Future Competitiveness
Key Takeaways Geopolitical risks, trade barriers, and climate regulations threaten to increase costs, reduce market access, and limit Micron's ability to invest or return capital. Shifts toward custom AI hardware and intense industry competition risk eroding core product demand and compressing profit margins amid volatile market cycles.
View narrative
US$102.10
FV
22.7% overvalued
intrinsic discount
14.47%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
Lam Research
AN
AnalystLowTarget
Consensus Narrative from 30 Analysts
China Exposure And Export Limits Will Compress Semiconductor Margins
Key Takeaways Export controls and rising local competition threaten revenue growth and pricing power, especially given Lam's heavy reliance on the Chinese market. High R&D demands and tightening sustainability regulations are likely to compress margins and increase ongoing compliance and operating expenses.
View narrative
US$82.00
FV
30.9% overvalued
intrinsic discount
4.82%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
Elevance Health
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
ACA And Medicaid Will Squeeze Margins Though Tech Will Aid
Key Takeaways Elevated costs in government-backed plans and greater reliance on value-based care could compress margins despite operational improvements and diversification strategies. Increasing regulatory changes, political uncertainty, and provider sophistication in technology may erode pricing power and add to earnings volatility.
View narrative
US$297.00
FV
0.5% undervalued
intrinsic discount
6.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
5 days ago
author updated this narrative
Eli Lilly
AN
AnalystLowTarget
Consensus Narrative from 26 Analysts
Drug Pricing Reforms And Patent Expiry Will Constrain Outcomes
Key Takeaways Potential drug pricing reforms and wider pricing parity efforts threaten future profitability and limit pricing power, especially for high-profile obesity and diabetes products. Heavy revenue reliance on a few core drugs and rising R&D demands increase vulnerability to competition, patent loss, and adverse data, risking future growth and margins.
View narrative
US$650.00
FV
5.3% overvalued
intrinsic discount
13.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
5 days ago
author updated this narrative
UnitedHealth Group
AN
AnalystLowTarget
Consensus Narrative from 24 Analysts
Medicare Scrutiny Will Deepen Margin Compression In Managed Care
Key Takeaways Government scrutiny, regulatory interventions, and policy headwinds are likely to reduce margins and profitability across UnitedHealth's core business segments. Rising medical costs, intensifying competition, and operational challenges threaten revenue growth, expose structural weaknesses, and endanger long-term earnings potential.
View narrative
US$198.00
FV
37.1% overvalued
intrinsic discount
3.36%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
5 days ago
author updated this narrative
Oracle
AN
AnalystLowTarget
Consensus Narrative from 34 Analysts
Legacy Model Will Falter Amid Rising Compliance And Cloud Competition
Key Takeaways Reliance on legacy platforms and shifting customer preferences threaten core revenue streams, gross margins, and create heightened long-term volatility for future income. Intensifying competition and regulatory demands will increase compliance costs and further diminish Oracle's pricing power, scalability, and overall growth potential.
View narrative
US$175.00
FV
40.0% overvalued
intrinsic discount
15.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies